Richard Ho, M.D., MSCI, associate professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $250,000 Hyundai Hope On Wheels Scholar Grant to study ways to reduce long-term side effects of chemotherapy in pediatric cancer survivors and develop more personalized therapies for pediatric oncology patients.

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.

Construction is underway at Monroe Carell Jr. Children’s Hospital at Vanderbilt for a planned four-floor expansion that will advance the size and scope of the hospital’s comprehensive array of specialty and subspecialty pediatric health care programs.

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.

How many heart transplant programs do we really need? That was a question posed by a group of investigators, including Vanderbilt University Medical Center’s Ashish Shah, M.D., in a novel study that used a computerized algorithm to highlight the value of high-volume transplant centers with corresponding improved outcomes.

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”